Correlation Engine 2.0
Clear Search sequence regions


Drug-eluting stents (DES) have significantly improved the rate of target vessel revascularization in comparison with bare metal stents. DES fracture was not reported in multicenter randomized clinical trials, but several case reports of DES fracture have been published, mostly with sirolimus-eluting stents. DES fracture is associated with stent restenosis and thrombosis. We report a zotarolimus-eluting stent fracture in an aortocoronary saphenous vein graft (SVG) bypass. The patient presented with chest pain and a non-ST-elevation myocardial infarction. He underwent cardiac catheterization that showed a complete fracture of a zotarolimus-eluting stent in the ostium of a sequential SVG to the diagonal and obtuse coronary arteries. His management included coronary angioplasty and retrieval of the proximal fractured segment. We discuss the potential causes for this stent fracture and suggest caution when using a DES in an ostial location of a SVG bypass, especially in a highly mobile vessel. Copyright © 2012 Wiley Periodicals, Inc.

Citation

Carmelo V Venero, Venkata R Aligeti, Dale C Wortham. A completely fractured zotarolimus-eluting stent in an aortocoronary saphenous vein bypass graft. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2013 Jan 1;81(1):62-5

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22553171

View Full Text